āagman

Not investment advice. Data and computed figures, for information only.

Strides Pharma Science Ltd

NSE: STAR
₹1,045.20
−₹14.70 (−1.39%)
NSE · 16 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹10,004 Cr
CMP
₹1,045.20
52-wk High / Low
₹1,261 / 769
P/E
17.3
P/B
3.2
Book Value
₹337.0
Div Yield
0.46%
ROCE
18.0%
ROE
20.0%
Face Value
₹10
D/E
0.57

Price+25.9% over 1Y

āagman read

Computed by āagman
Derived from 12 years and 13 quarters of filings. Not reported by the company.
As of 16 Oct 2026
How we compute these
Piotroski F-Score
6
/ 9
6 of 9 F-score tests passed
Graham Number
₹676
√(22.5 × EPS × book value per share)
ROIC
12.8%
vs 11.2% sector median
Cash flow to profit
1.22
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
−144
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
18.4%
ROE × earnings retention ratio
ROE stability
59.3
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII −0.28DII +0.98
Latest quarter vs the previous one
Cash-accrual divergence
−2.0%
of assets
Low = accruals track cash flow
Strengths
+Borrowings are down 50.4% since FY2016 (3542 to 1758)
+Price trades above its 200-day moving average (1.0x)
+FII holding rose by 9.5pp over the last year
+PE of 17.3x is below the sector median of 45.9x
Watch-outs
−Promoter holding fell by 0.4pp over the last year

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales9309991,0061,0441,0541,1671,1541,1901,1201,2211,1951,3231,265
Expenses7968898768748669839439739029909591,0841,037
Operating Profit134111129169188184210218218231236240228
OPM %14.4%11.1%12.8%16.2%17.8%15.8%18.2%18.3%19.5%18.9%19.7%18.1%18.0%
Other Income3−12960−273,299254−12018104368
Interest76797071737452504746434241
Depreciation60604948474848494950515356
Profit before tax0−15770233,36986114106122153245148200
Net Profit−9−14954103,350729086106132208129165
EPS (₹)−0.79−14.545.401.98364.697.819.548.9110.8013.8421.9313.7717.02

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 12 years + TTM
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,1962,8612,7552,8452,1782,7523,3163,0703,6883,8904,5654,8595,004
Expenses9672,4862,2282,4481,9822,3382,7793,2013,5443,3623,7633,9334,070
Operating Profit229374527398197414537−131145528803925935
OPM %19.1%13.1%19.1%14.0%9.0%15.0%16.2%−4.3%3.9%13.6%17.6%19.0%18.7%
Other Income87463291643303−43109−11292−1003,313124193
Interest4716818319679156150177261280249179172
Depreciation64131126154117174206233243214192202210
Profit before tax99213750969030342289−653−268−653,675669746
Net Profit8449544668433031258−474−212−943,598575634
EPS (₹)141.7812.1544.7174.2536.274.0629.93−51.25−22.44−7.68389.7560.3466.56

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital608989909090909090929292—
Reserves1,0852,5692,6592,3742,5592,4382,6872,2692,1222,0342,4603,015—
Borrowings8923,5423,7002,5203,2212,2352,3483,0253,0302,5171,8801,758—
Other Liabilities4381,2111,5981,6011,9371,3691,8441,5561,3521,1571,4981,941—
Total Liabilities2,4757,4108,0466,5857,8076,1316,9696,9406,5945,7995,9296,807—
Fixed Assets7012,6792,9802,9773,6482,0992,2192,3472,3111,8651,8992,101—
CWIP171815780620453413447291151162207447—
Investments6301,3411,525588702549697540490303409291—
Other Assets9722,5762,7622,4003,0053,0703,6053,7623,6423,4703,4143,967—
Total Assets2,4757,4108,0466,5857,8076,1316,9696,9406,5945,7995,9296,807—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity837328818760205481−25844701684703
Cash from Investing Activity50−2,205−1,222570−1451,321−522−119302−150−90−173
Cash from Financing Activity−4212,944338−1,016194−1,709−16421−214−693−643−453
Net Cash Flow−288812−596−259110−184−5645133−142−4876

Ratios

As of 31 Mar 2026
12 periods
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %57.08.011.016.02.05.08.0−5.00.07.015.018.0
ROE %———————————20.0
EPS (₹)141.7812.1544.7174.2536.274.0629.93−51.25−22.44−7.68389.7560.34
Book Value (₹)———————————337.0
Face Value (₹)———————————10
P/E———————————17.3
Div Yield %———————————0.46
NPM %40.83.214.619.613.31.17.5−16.0−5.6−2.545.711.5
OPM %19.013.019.014.09.015.016.0−4.33.914.018.019.0
D/E0.781.331.351.021.220.880.851.281.371.180.740.57
P/B———————————3.2

Growth

As of 11 Oct 2026
Compounded sales growth
10 years+5.0%
5 years+8.0%
3 years+10.0%
TTM+8.0%
Compounded profit growth
10 years+16.0%
5 years+20.0%
3 years+71.0%
TTM+55.0%
Stock price CAGR
10 years+9.0%
5 years+31.0%
3 years+65.0%
Last year+28.0%
Return on equity
10 years22.0%
5 years31.0%
3 years57.0%
Last year20.0%

Shareholding pattern

As of 31 Mar 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters31.09%31.09%31.36%31.24%31.27%29.67%30.60%28.28%25.88%28.30%27.91%27.91%
FIIs34.49%34.49%31.48%25.23%28.80%24.82%19.66%18.85%24.57%28.32%28.68%28.40%
DIIs14.40%14.40%19.84%24.19%18.88%16.08%18.82%17.88%17.66%13.72%14.44%15.42%
Government0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.40%0.39%0.01%0.01%0.01%
Public20.02%20.02%17.32%19.34%21.05%29.42%30.92%34.60%31.52%29.65%28.96%28.28%
No. of shareholders64,43864,43872,56679,39673,26574,0741,33,1901,20,91684,69595,12586,61694,850
Change since Jun 2023 (pp)
Promoters −3.18FIIs −6.09DIIs +1.02Public +8.26

Documents

As of 11 Oct 2026
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Closure of Trading WindowStrides'' Sustainability Report For FY26Completion Of USFDA Inspection At The Company''s Formulations Facility At AlathurAnnouncement under Regulation 30 (LODR)-Press Release / Media Release
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Aug 2026TranscriptAug 2026PPTAug 2026RecordingMay 2026TranscriptMay 2026PPTMay 2026RecordingFeb 2026TranscriptFeb 2026PPTNov 2025TranscriptNov 2025PPTAug 2025TranscriptAug 2025PPTAug 2025Recording

Corporate actions

As of 31 Jul 2026
31 Jul 2026DIVIDENDDividend - Rs 5 Per Share—
22 Jul 2025DIVIDENDDividend - Rs 4 Per Share—
6 Dec 2024DEMERGERDemerger—
9 Sep 2024DIVIDENDDividend - Rs 2.50 Per Share—
4 Aug 2023DIVIDENDDividend - Rs 1.50 Per Share—
5 Aug 2021DIVIDEND Dividend - Rs 2.50 Per Share—
24 Jul 2020DIVIDEND Annual General Meeting/Dividend - Rs 2 Per Share—
22 Aug 2019DIVIDEND Interim Dividend - Rs 12 Per Share—
19 Jul 2019DIVIDEND Annual General Meeting/Dividend - Rs 3 Per Share—
12 Sep 2018DIVIDEND Annual General Meeting/Dividend Rs 2 Per Share—
6 Apr 2018DEMERGER Scheme Of Arrangement—
7 Sep 2017DIVIDEND Annual General Meeting/Dividend - Rs 4.50 Per Share—
21 Jul 2016DIVIDEND Annual General Meeting/ Dividend - Rs 4/- Per Share—
22 Jul 2015DIVIDENDAnnual General Meeting/ Dividend - Rs 3/- Per Share—
16 Oct 2014DIVIDENDSpecial Dividend Rs.105/- Per Share—
1 Sep 2014DIVIDENDAnnual General Meeting / Dividend - Rs 5/- Per Share—
19 Dec 2013DIVIDENDSpecial Dividend - Rs 500/- Per Share—
30 May 2013DIVIDENDAnnual General Meeting And Dividend Rs.2/- Per Share—
14 May 2012DIVIDENDAnnual General Meeting And Dividend Rs.2/- Per Share—
18 May 2011DIVIDENDAnnual General Meeting And Dividend Rs.1.50 Per Share—
21 May 2010DIVIDENDAnnual General Meeting And Dividend Rs.1.50 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman